CCL5 and acute myeloid leukemia: Besides, CCL5 is physiologically a regulator of immune cell migration and is currently identified as a unique chemokine in AML and a critical mediator in inducing resistance to FLT-ITD tyrosine kinase inhibitors (Waldeck et al., 2020).